Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain
dc.contributor.author | Bohn, Markus-Frederik | |
dc.contributor.author | Shandilya, Shivender M. D. | |
dc.contributor.author | Albin, John S. | |
dc.contributor.author | Kouno, Takahide | |
dc.contributor.author | Anderson, Brett D. | |
dc.contributor.author | McDougle, Rebecca M. | |
dc.contributor.author | Carpenter, Michael A. | |
dc.contributor.author | Rathore, Anurag | |
dc.contributor.author | Evans, Leah | |
dc.contributor.author | Davis, Ahkillah N. | |
dc.contributor.author | Zhang, JingYing | |
dc.contributor.author | Lu, Yongjian | |
dc.contributor.author | Somasundaran, Mohan | |
dc.contributor.author | Matsuo, Hiroshi | |
dc.contributor.author | Harris, Reuben S. | |
dc.contributor.author | Schiffer, Celia A. | |
dc.date | 2022-08-11T08:08:29.000 | |
dc.date.accessioned | 2022-08-23T15:56:32Z | |
dc.date.available | 2022-08-23T15:56:32Z | |
dc.date.issued | 2013-06-04 | |
dc.date.submitted | 2013-06-05 | |
dc.identifier.citation | Structure. 2013 Jun 4;21(6):1042-50. doi: 10.1016/j.str.2013.04.010. <a href="http://dx.doi.org/10.1016/j.str.2013.04.010" target="_blank">Link to article on publisher's site</a> | |
dc.identifier.issn | 0969-2126 (Linking) | |
dc.identifier.doi | 10.1016/j.str.2013.04.010 | |
dc.identifier.pmid | 23685212 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/29989 | |
dc.description.abstract | Human APOBEC3F is an antiretroviral single-strand DNA cytosine deaminase, susceptible to degradation by the HIV-1 protein Vif. In this study the crystal structure of the HIV Vif binding, catalytically active, C-terminal domain of APOBEC3F (A3F-CTD) was determined. The A3F-CTD shares structural motifs with portions of APOBEC3G-CTD, APOBEC3C, and APOBEC2. Residues identified to be critical for Vif-dependent degradation of APOBEC3F all fit within a predominantly negatively charged contiguous region on the surface of A3F-CTD. Specific sequence motifs, previously shown to play a role in Vif susceptibility and virion encapsidation, are conserved across APOBEC3s and between APOBEC3s and HIV-1 Vif. In this structure these motifs pack against each other at intermolecular interfaces, providing potential insights both into APOBEC3 oligomerization and Vif interactions. | |
dc.language.iso | en_US | |
dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23685212&dopt=Abstract">Link to Article in PubMed</a> | |
dc.relation.url | http://dx.doi.org/10.1016/j.str.2013.04.010 | |
dc.subject | Cytosine Deaminase | |
dc.subject | vif Gene Products, Human Immunodeficiency Virus | |
dc.subject | Biochemistry, Biophysics, and Structural Biology | |
dc.subject | Immunology and Infectious Disease | |
dc.title | Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding Domain | |
dc.type | Journal Article | |
dc.source.journaltitle | Structure (London, England : 1993) | |
dc.source.volume | 21 | |
dc.source.issue | 6 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/faculty_pubs/22 | |
dc.identifier.contextkey | 4199952 | |
html.description.abstract | <p>Human APOBEC3F is an antiretroviral single-strand DNA cytosine deaminase, susceptible to degradation by the HIV-1 protein Vif. In this study the crystal structure of the HIV Vif binding, catalytically active, C-terminal domain of APOBEC3F (A3F-CTD) was determined. The A3F-CTD shares structural motifs with portions of APOBEC3G-CTD, APOBEC3C, and APOBEC2. Residues identified to be critical for Vif-dependent degradation of APOBEC3F all fit within a predominantly negatively charged contiguous region on the surface of A3F-CTD. Specific sequence motifs, previously shown to play a role in Vif susceptibility and virion encapsidation, are conserved across APOBEC3s and between APOBEC3s and HIV-1 Vif. In this structure these motifs pack against each other at intermolecular interfaces, providing potential insights both into APOBEC3 oligomerization and Vif interactions.</p> | |
dc.identifier.submissionpath | faculty_pubs/22 | |
dc.contributor.department | Department of Biochemistry and Molecular Pharmacology | |
dc.contributor.department | Department of Pediatrics | |
dc.source.pages | 1042-50 |